Literature DB >> 30244148

Theranostic polymeric nanoparticles for NIR imaging and photodynamic therapy.

E Tugce Sarcan1, Mine Silindir-Gunay2, A Yekta Ozer3.   

Abstract

Near-Infrared (NIR) dyes forming some of the photosensitizer agents show imaging and therapy features by themselves. NIR dyes show photodynamic therapy by formation of reactive oxygen species and imaging by NIR Fluorescence light. Photodynamic therapy occurs from irradiation of laser or light to photosensitizer matters and following by the formation of reactive oxygen species diseased tissues or cells can be killed effectively. NIR dyes have advantages such as stability, high specificity and sensitivity when compared with the other photosensitizer and imaging agents. Drug delivery systems are getting attention for either diagnosis or therapy of almost all of the diseases. Theranostic nanoparticles comprise the substances which shows the imaging and treatment features together. Besides, the combination of active substance and the imaging agent can also be encapsulated in theranostic nanoparticles. Many researchs are performed to evaluate the efficacy of theranostic drug delivery systems particularly polymeric nanoparticles in order to enhance targeting properties, specificity and bioavailability. Polymeric nanoparticles give advantages because of easier degradation properties when compared with the others. Theranostic polymeric nanoparticles can be used for NIR imaging and photodynamic therapy of several diseases especially cancers.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  NIR dyes; NIR imaging; Nanoparticle preparation; Photodynamic therapy; Theranostic polymeric nanoparticles

Mesh:

Substances:

Year:  2018        PMID: 30244148     DOI: 10.1016/j.ijpharm.2018.09.019

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

Review 1.  A promising anticancer drug: a photosensitizer based on the porphyrin skeleton.

Authors:  Qizhi Zhang; Jun He; Wenmei Yu; Yanchun Li; Zhenhua Liu; Binning Zhou; Yunmei Liu
Journal:  RSC Med Chem       Date:  2020-02-25

Review 2.  Exploring the link between chronobiology and drug delivery: effects on cancer therapy.

Authors:  Tânia Albuquerque; Ana R Neves; Telma Quintela; Diana Costa
Journal:  J Mol Med (Berl)       Date:  2021-07-02       Impact factor: 4.599

3.  Protein Based Biomaterials for Therapeutic and Diagnostic Applications.

Authors:  Stanley Chu; Andrew L Wang; Aparajita Bhattacharya; Jin Kim Montclare
Journal:  Prog Biomed Eng (Bristol)       Date:  2021-10-26

4.  Formulation of Folate-Modified Raltitrexed-Loaded Nanoparticles for Colorectal Cancer Theranostics.

Authors:  Justin G Rosch; Allison N DuRoss; Madeleine R Landry; Conroy Sun
Journal:  Pharmaceutics       Date:  2020-02-05       Impact factor: 6.321

Review 5.  Application of Biocompatible Drug Delivery Nanosystems for the Treatment of Naturally Occurring Cancer in Dogs.

Authors:  Nicola Ambrosio; Silvia Voci; Agnese Gagliardi; Ernesto Palma; Massimo Fresta; Donato Cosco
Journal:  J Funct Biomater       Date:  2022-08-07

Review 6.  Recent advances in nanoparticle-based targeting tactics for antibacterial photodynamic therapy.

Authors:  Brydie A Thomas-Moore; Carla Arnau Del Valle; Robert A Field; María J Marín
Journal:  Photochem Photobiol Sci       Date:  2022-04-06       Impact factor: 4.328

7.  The Formulation of Methylene Blue Encapsulated, Tc-99m Labeled Multifunctional Liposomes for Sentinel Lymph Node Imaging and Therapy.

Authors:  Mine Sİlİndİr GÜnay
Journal:  Turk J Pharm Sci       Date:  2020-08-28

8.  γ-Glutamyl transpeptidase-activatable near-infrared nanoassembly for tumor fluorescence imaging-guided photothermal therapy.

Authors:  Fangyuan Zhou; Shikui Yang; Chao Zhao; Wangwang Liu; Xufeng Yao; Hui Yu; Xiaolian Sun; Yi Liu
Journal:  Theranostics       Date:  2021-05-13       Impact factor: 11.556

Review 9.  Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics.

Authors:  Shahryar Shakeri; Milad Ashrafizadeh; Ali Zarrabi; Rasoul Roghanian; Elham Ghasemipour Afshar; Abbas Pardakhty; Reza Mohammadinejad; Anuj Kumar; Vijay Kumar Thakur
Journal:  Biomedicines       Date:  2020-01-13

Review 10.  Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid.

Authors:  Jingwei Shao; Yifan Fang; Ruirui Zhao; Fangmin Chen; Mingyue Yang; Jiali Jiang; Zixuan Chen; Xiaotian Yuan; Lee Jia
Journal:  Asian J Pharm Sci       Date:  2020-03-21       Impact factor: 6.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.